| CMP | cardiomyopathy; cartilage matrix protein; chondromalacia patellae; collagen binding protein; competi... |
|---|---|
| CPB | carboxypeptidase B; cardiopulmonary bypass; cetylpyridinium bromide; competitive protein binding |
| CPBA | competitive protein-binding analysis |
| VOO | ventricular asynchronous (competitive, fixed-rate) [pacemaker] |
| competitive antagonist |
An antagonist that works by competing with the neurotransmitter for the same binding site.
출처: www.third-plateau.org/faq/dxm_glossary.shtml
|
|---|---|
| competitive inhibitor |
1. A chemical that binds to or blocks another reagent from participating in a reaction. 2. A medication, hormone, or other intercellular messenger that binds and blocks the cellular receptor or target enzyme of another ag
출처:
|
| competitive a. |
a substance that competes with a substrate or with an enzyme which ordinarily attacks the substrate, thus interfering with usual metabolic activity. The antagonist is usually a substrate analogue. See antimetabolite.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| competitive e. |
the tendency for the better adapted species to exclude another related species from its particular ecological niche. See also character displacement, under displacement.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| competitive i. |
inhibition of enzyme activity in which the inhibitor (substrate analogue) reversibly combines with catalytic sites, thus competing with the substrate for binding on the enzyme. The inhibition is reversible since it can be overcome by increasing the substrate concentration. Similarly, the reversible binding of a physiologic antagonist to a receptor site for a hormone or neurotransmitter.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|